Company Filing History:
Years Active: 2010
Title: Innovations in Eye Treatment by Hans-Markus Bender
Introduction
Hans-Markus Bender is a notable inventor based in Munich, Germany. He has made significant contributions to the field of ophthalmology through his innovative patents. With a total of 2 patents, Bender's work focuses on methods and compositions for the treatment of diseases affecting the eye.
Latest Patents
Bender's latest patents include groundbreaking methods for treating eye diseases. One patent details methods and compositions for the prophylaxis and treatment of eye diseases resulting from angiogenesis. This involves using antagonists of the integrin receptors αvβ3 and/or αvβ5, with compositions that can be nanoparticles administered via injection into the sclera of the eye. Another patent focuses on integrin inhibitors for treating eye diseases, which includes injecting a composition containing a therapeutically effective amount of an αvβ3 and/or αvβ5 inhibitor into the vitreous body of the eye. This method aims to inhibit angiogenesis and neovascularization in the treated eye.
Career Highlights
Bender is currently associated with Merck Patent GmbH, where he continues to develop innovative solutions for eye care. His work has been instrumental in advancing treatment options for patients suffering from various eye conditions.
Collaborations
Bender collaborates with esteemed colleagues such as Jutta Haunschild and Ulrich Lang, contributing to a dynamic research environment focused on ophthalmic innovations.
Conclusion
Hans-Markus Bender's contributions to the field of eye treatment through his patents reflect his commitment to improving patient care. His innovative approaches are paving the way for new therapeutic options in ophthalmology.